43/120
1.8 / 5 stars
All 120 Win/Lose results shown below
EVH Roast Me summary
Evolent Health, Inc. (EVH). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Win; Revenue growth Lose; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Lose; Revenue growth Lose; EPS growth Lose.
Trailing 1 year (4 quarters): 1 wins, 11 lossesLast fetched: 25 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
WinEVH / S&P 137.72% / 15.20% |
LoseEVH / S&P -4.50% / 15.00% |
LoseEVH / S&P EVH unavailable / 50.40% |
| 2026-Q10/3 |
LoseEVH / S&P -43.00% / -4.33% |
LoseEVH / S&P -21.26% / 11.30% |
LoseEVH / S&P EVH unavailable / 27.70% |
| 2025-Q40/3 |
LoseEVH / S&P -52.72% / 2.65% |
LoseEVH / S&P -26.56% / 9.00% |
LoseEVH / S&P EVH unavailable / 13.40% |
| 2025-Q30/3 |
LoseEVH / S&P -24.87% / 8.12% |
LoseEVH / S&P -16.65% / 4.61% |
LoseEVH / S&P EVH unavailable / 13.45% |
| 2025-Q21/3 |
WinEVH / S&P 18.90% / 10.94% |
LoseEVH / S&P -6.71% / 4.83% |
LoseEVH / S&P EVH unavailable / 10.63% |
| 2025-Q11/3 |
LoseEVH / S&P -15.82% / -4.27% |
WinEVH / S&P 10.24% / 4.98% |
LoseEVH / S&P EVH unavailable / 10.57% |
| 2024-Q41/3 |
LoseEVH / S&P -60.22% / 2.41% |
WinEVH / S&P 30.09% / 5.25% |
LoseEVH / S&P EVH unavailable / 6.15% |
| 2024-Q32/3 |
WinEVH / S&P 47.91% / 5.89% |
WinEVH / S&P 37.65% / 5.89% |
LoseEVH / S&P EVH unavailable / 6.11% |
| 2024-Q21/3 |
LoseEVH / S&P -41.69% / 4.28% |
WinEVH / S&P 44.25% / 5.38% |
LoseEVH / S&P EVH unavailable / 5.12% |
| 2024-Q11/3 |
LoseEVH / S&P -0.73% / 10.56% |
WinEVH / S&P 46.76% / 5.71% |
LoseEVH / S&P EVH unavailable / 5.59% |
| 2023-Q42/3 |
WinEVH / S&P 21.30% / 11.69% |
WinEVH / S&P 45.26% / 6.81% |
LoseEVH / S&P EVH unavailable / 7.78% |
| 2023-Q31/3 |
LoseEVH / S&P -10.13% / -3.27% |
WinEVH / S&P 46.99% / 7.52% |
LoseEVH / S&P EVH unavailable / -5.03% |
| 2023-Q21/3 |
LoseEVH / S&P -6.63% / 8.74% |
WinEVH / S&P 50.01% / 9.50% |
LoseEVH / S&P EVH unavailable / -8.57% |
| 2023-Q12/3 |
WinEVH / S&P 15.56% / 7.50% |
WinEVH / S&P 49.77% / 10.77% |
LoseEVH / S&P EVH unavailable / -15.69% |
| 2022-Q41/3 |
LoseEVH / S&P -21.85% / 7.56% |
WinEVH / S&P 48.91% / 11.88% |
LoseEVH / S&P EVH unavailable / -17.99% |
| 2022-Q32/3 |
WinEVH / S&P 17.00% / -4.88% |
WinEVH / S&P 46.08% / 13.47% |
LoseEVH / S&P EVH unavailable / -1.41% |
| 2022-Q22/3 |
WinEVH / S&P -4.92% / -16.10% |
WinEVH / S&P 24.20% / 13.71% |
LoseEVH / S&P EVH unavailable / 11.04% |
| 2022-Q11/3 |
WinEVH / S&P 16.73% / -4.60% |
LoseEVH / S&P 10.93% / 15.97% |
LoseEVH / S&P EVH unavailable / 42.23% |
| 2021-Q40/3 |
LoseEVH / S&P -10.74% / 11.03% |
LoseEVH / S&P -1.80% / 15.00% |
LoseEVH / S&P EVH unavailable / 96.40% |
| 2021-Q31/3 |
WinEVH / S&P 46.78% / 0.58% |
LoseEVH / S&P -15.53% / 10.77% |
LoseEVH / S&P EVH unavailable / 69.42% |
| 2021-Q20/3 |
LoseEVH / S&P 4.55% / 8.55% |
LoseEVH / S&P -7.08% / 6.58% |
LoseEVH / S&P EVH unavailable / 51.81% |
| 2021-Q12/3 |
WinEVH / S&P 26.01% / 6.17% |
WinEVH / S&P -0.39% / -1.06% |
LoseEVH / S&P EVH unavailable / 7.39% |
| 2020-Q42/3 |
WinEVH / S&P 29.17% / 12.15% |
WinEVH / S&P 9.25% / -3.72% |
LoseEVH / S&P EVH unavailable / -33.42% |
| 2020-Q32/3 |
WinEVH / S&P 74.30% / 8.93% |
WinEVH / S&P 22.92% / -2.04% |
LoseEVH / S&P EVH unavailable / -27.10% |
| 2020-Q22/3 |
WinEVH / S&P 31.12% / 20.54% |
WinEVH / S&P 28.63% / -0.46% |
LoseEVH / S&P EVH unavailable / -27.11% |
| 2020-Q11/3 |
LoseEVH / S&P -40.00% / -19.60% |
WinEVH / S&P 30.77% / 3.47% |
LoseEVH / S&P EVH unavailable / -14.75% |
| 2019-Q42/3 |
WinEVH / S&P 25.87% / 9.07% |
WinEVH / S&P 34.98% / 5.36% |
LoseEVH / S&P EVH unavailable / 2.99% |
| 2019-Q31/3 |
LoseEVH / S&P -9.56% / 1.70% |
WinEVH / S&P 46.61% / 5.02% |
LoseEVH / S&P EVH unavailable / 0.21% |
| 2019-Q21/3 |
LoseEVH / S&P -36.80% / 4.30% |
WinEVH / S&P 44.91% / 6.64% |
LoseEVH / S&P EVH unavailable / 8.65% |
| 2019-Q11/3 |
LoseEVH / S&P -36.94% / 13.65% |
WinEVH / S&P 46.26% / 8.12% |
LoseEVH / S&P EVH unavailable / 14.29% |
| 2018-Q41/3 |
LoseEVH / S&P -29.75% / -13.52% |
WinEVH / S&P 44.17% / 9.05% |
LoseEVH / S&P EVH unavailable / 18.23% |
| 2018-Q31/3 |
WinEVH / S&P 34.92% / 7.71% |
LoseEVH / S&P EVH unavailable / 10.21% |
LoseEVH / S&P EVH unavailable / 19.06% |
| 2018-Q21/3 |
WinEVH / S&P 47.72% / 3.43% |
LoseEVH / S&P EVH unavailable / 9.03% |
LoseEVH / S&P EVH unavailable / 14.46% |
| 2018-Q11/3 |
WinEVH / S&P 15.85% / -0.76% |
LoseEVH / S&P EVH unavailable / 7.68% |
LoseEVH / S&P EVH unavailable / 12.46% |
| 2017-Q41/3 |
LoseEVH / S&P -30.90% / 6.64% |
WinEVH / S&P 71.11% / 7.03% |
LoseEVH / S&P EVH unavailable / 13.82% |
| 2017-Q30/3 |
LoseEVH / S&P -29.78% / 4.48% |
LoseEVH / S&P EVH unavailable / 5.68% |
LoseEVH / S&P EVH unavailable / 17.57% |
| 2017-Q21/3 |
WinEVH / S&P 13.68% / 3.09% |
LoseEVH / S&P EVH unavailable / 4.83% |
LoseEVH / S&P EVH unavailable / 17.74% |
| 2017-Q11/3 |
WinEVH / S&P 50.68% / 6.07% |
LoseEVH / S&P EVH unavailable / 3.67% |
LoseEVH / S&P -118.26% / 13.32% |
| 2016-Q40/3 |
LoseEVH / S&P -39.89% / 3.82% |
LoseEVH / S&P EVH unavailable / 2.09% |
LoseEVH / S&P -151.23% / 7.05% |
| 2016-Q31/3 |
WinEVH / S&P 28.23% / 3.85% |
LoseEVH / S&P EVH unavailable / 0.20% |
LoseEVH / S&P -924.53% / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | EVH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -52.18% | 20.78% |
| Annualized return | -52.18% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | EVH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -81.41% | 83.14% |
| Annualized return | -28.57% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | EVH total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -81.56% | 319.30% |
| Annualized return | -15.56% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-25.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FRANKLIN COVEY CO (FC) | United States | $0.195B | 123.76 |
| GARTNER INC (IT) | United States | $11.326B | 11.20 |